Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation

View through CrossRef
Brown and beige adipocytes are characterized as thermogenic adipocytes and have great potential for treating obesity and associated metabolic diseases. Here, we identify a conserved mammalian lysine 79 of histone H3 (H3K79) methyltransferase, disruptor of telomeric silencing -1 like (DOT1L), as a new epigenetic regulator that controls thermogenic adipocyte differentiation and function. We show that deletion of DOT1L in thermogenic adipocytes potently protects mice from diet-induced obesity, improves glucose homeostasis, alleviates hepatic steatosis, and facilitates adaptive thermogenesis<i> in vivo</i>. Loss of DOT1L in primary preadipocytes significantly promotes brown and beige adipogenesis and thermogenesis<i> in vitro</i>. Mechanistically, DOT1L epigenetically regulates the BAT-selective gene program through modulating H3K79 methylation, in particular H3K79me2 modification. Thus, our study demonstrates that DOT1L exerts an important role in energy homeostasis by regulating thermogenic adipocyte differentiation and function.
Title: DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
Description:
Brown and beige adipocytes are characterized as thermogenic adipocytes and have great potential for treating obesity and associated metabolic diseases.
Here, we identify a conserved mammalian lysine 79 of histone H3 (H3K79) methyltransferase, disruptor of telomeric silencing -1 like (DOT1L), as a new epigenetic regulator that controls thermogenic adipocyte differentiation and function.
We show that deletion of DOT1L in thermogenic adipocytes potently protects mice from diet-induced obesity, improves glucose homeostasis, alleviates hepatic steatosis, and facilitates adaptive thermogenesis<i> in vivo</i>.
Loss of DOT1L in primary preadipocytes significantly promotes brown and beige adipogenesis and thermogenesis<i> in vitro</i>.
Mechanistically, DOT1L epigenetically regulates the BAT-selective gene program through modulating H3K79 methylation, in particular H3K79me2 modification.
Thus, our study demonstrates that DOT1L exerts an important role in energy homeostasis by regulating thermogenic adipocyte differentiation and function.

Related Results

DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
Brown and beige adipocytes are characterized as thermogenic adipocytes and have great potential for treating obesity and associated metabolic diseases. Here, we identify a conserve...
Connecting the DOTs on Cell Identity
Connecting the DOTs on Cell Identity
DOT1-Like (DOT1L) is the sole methyltransferase of histone H3K79, a modification enriched mainly on the bodies of actively transcribing genes. DOT1L has been extensively studied in...
2044-P: Histone Methyltransferase DOT1L Regulates Brown Adipocyte Differentiation and Thermogenesis
2044-P: Histone Methyltransferase DOT1L Regulates Brown Adipocyte Differentiation and Thermogenesis
Brown fat has been extensively studied due to its potential in therapies against obesity. Various epigenetic regulators have been shown to modulate brown fat development and functi...
MDR1 Mediated Drug Resistance to a Histone Methyltansferase Inhibitor (KMT)
MDR1 Mediated Drug Resistance to a Histone Methyltansferase Inhibitor (KMT)
Abstract Aberrant histone methylation is emerging as a major contributor to oncogenesis, and inhibitors of histone lysine methyltransferases (KMTs) are starting to e...
Abstract 1654: Discovery of the first-in-class DOT1L PROTAC degrader
Abstract 1654: Discovery of the first-in-class DOT1L PROTAC degrader
The histone methyltransferase, DOT1L is often dysregulated in MLL-rearranged (MLL-r) leukemia, which leads to hyperactivation of MLL target genes and poor prognosis. This dysregula...
Dual function of DOT1L suppresses tumor intrinsic immunogenicity in hepatocellular carcinoma
Dual function of DOT1L suppresses tumor intrinsic immunogenicity in hepatocellular carcinoma
AbstractImmune checkpoint inhibitor (ICB) therapy for many cancers remains limited in patients’ overall response rate. Discovery and development of more effective combinatorial app...

Back to Top